Close

Form 6-K AnPac Bio-Medical Scienc For: Oct 03

October 3, 2022 6:12 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2022

 

Commission File Number: 001-39137

 

AnPac Bio-Medical Science Co., Ltd.

 

801 Bixing Street, Bihu County

Lishui, Zhejiang Province 323006

The People’s Republic of China

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

Amendments to Articles of Incorporation or Bylaws

 

AnPac Bio-Medical Science Co., Ltd. has adopted the Fourth Amended and Restated Memorandum and Articles of Association on May 19, 2022. The full text of the Fourth Amended and Restated Memorandum and Articles of Association is set forth in Exhibit 5.03 to this report

 

EXHIBIT INDEX

 

Exhibit   Description
5.03   Fourth Amended and Restated Memorandum and Articles of Association

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AnPac Bio-Medical Science Co., Ltd.
   
  By:  /s/ Dr. Chris Chang Yu
    Name:  Dr. Chris Chang Yu
    Title:  Co-Chairman of the Board of Directors and Co-Chief Executive Officer

 

Dated: October 3, 2022

 

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 5.03



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings